CLINICAL_TRIALS
trial_result
· 2014-09-25
Clinical Trial Update: Beryllium Infliximab Study: Clinical Interventional Trial [Phase 1, Phase 2]
Summary
Terminated Phase 1/2 interventional trial evaluating infliximab for Berylliosis and Beryllium disease, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Maier, Lisa, M.D. | Conditions: Berylliosis, Beryllium Disease | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2014-09-25